Donor Criteria
Clinical Trial Enrollment CompletedAbout Trial
- Pivotal Clinical Study Protocol
- Eligibility Criteria
- Donor Criteria
Lungs were eligible for use in this study when an OPO verified that those lungs would not otherwise be used for transplantation
The donor lung was excluded from EVLP if at least one of the following criteria had been met:
The donor lung had confirmed pneumonia and/or persistent purulent secretions identified via bronchoscopy prior to donor lung excision
Any purulent secretions not considered persistent identified in the donor lung prior to excision that did not clear by the hour 3 assessment of EVLP.
The donor lung had confirmed evidence of aspiration.
The donor lung had significant mechanical lung injury or trauma.
The donor had HIV or active Hepatitis C.
The CIT, starting at donor aortic cross clamp/initial flush (CIT-1), required to transport the lung from the donor site to start of the EVLP procedure at a Sponsor facility will be > 10 hrs.
Please fill out the form below to request more information about our study and to find out how to get involved.